MAOA and breast cancer: MAO-A may contribute to HIF-1α stabilization, promoting VEGF expression, ROS production, tumorigenesis, and metastasis [39], whereas, under conditions of hypoxia and IL-6 receptor activation in breast cancer cells, enhanced VEGF expression is associated with MAO-A suppression [40].